In addition, there are other known reversion therapeutic targets, TPT1/TCTP and SETDB1 from previous studies.[2, 3, 43] Although these studies do not provide Boolean network models, we can still suggest that the cancer reversion induced by inhibiting each target is comparable with the normalization of IO relationship. The gene discussed is SETDB1; the disease is cancer.